Jeff Cislini
General Counsel at Revolution Medicines, Inc. (RVMD)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $15.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 29SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 76551,776 held (−1%) | $207.32 | $159K | -8.5% |
| Sep 18SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 5255,855 held (−0%) | $195.01 | $10K | -2.7% |
| Sep 18SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 3,31452,541 held (−6%) | $199.30 | $660K | -4.8% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 3,400109,401 held (−3%) | $207.24 | $705K | -8.4% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 17,32392,078 held (−16%) | $208.37 | $3.6M | -8.9% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 25,81766,261 held (−28%) | $209.25 | $5.4M | -9.3% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 2,54063,721 held (−4%) | $210.26 | $534K | -9.7% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 4,50059,221 held (−7%) | $211.34 | $951K | -10.2% |
| Aug 25SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 3,31455,907 held (−6%) | $212.06 | $703K | -10.5% |
| Jun 18SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 2,15756,521 held (−4%) | $156.12 | $337K | +21.5% |
| Mar 19SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 1,79559,681 held (−3%) | $99.48 | $179K | +90.8% |
| Mar 19SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 1,16358,518 held (−2%) | $97.44 | $113K | +94.7% |
| Jan 23SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 90846,976 held (−2%) | $115.60 | $105K | +64.2% |
| Dec 18SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 2,68847,884 held (−5%) | $76.82 | $206K | +147.0% |
| Nov 20SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 13,38850,425 held (−21%) | $70.14 | $939K | +170.5% |
| Oct 20SEC | RVMDRevolution Medicines, Inc. | Sell Plan | 12,00050,425 held (−19%) | $55.00 | $660K | +245.0% |
- Sell
General Counsel Jeff Cislini sold $159K of RVMD at $207.32 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Jeff Cislini sold $10K of RVMD at $195.01 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Jeff Cislini sold $660K of RVMD at $199.30 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Jeff Cislini sold $705K of RVMD at $207.24 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Jeff Cislini sold $3.6M of RVMD at $208.37 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Jeff Cislini sold $5.4M of RVMD at $209.25 — cuts the stake by 28%; pre-scheduled 10b5-1 plan sale.